Technical Strength Analyser      Futures Screeners ,    Option Screeners
Stock Listing : A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z 

Stock Analysis of Aarti Drugs, Birds-Eye-view On Returns/Technicals/Funda/F&O

About Strength Screener

Charts Of Aarti Drugs

1D   1W   2W   1M   3M   1Y   2Y   5Y   
Interactive Charts

Price / Volume Action

EOD Share Price643.6
Previous Share Price637.2
Price Change 6.40
Change % 1.00%
Volume30.43 K
Five Day Avg Vol48.21 K
Last Business Date19-Feb-20

Price Gain/Loss

DurationAbsolute ChgChg %
One Week 25.00 4.04
Two Weeks 16.25 2.59
One Month 16.95 2.70
Three Months 122.70 23.56
Six Months 181.75 39.35
One Year 58.70 10.04

Highs / Lows

One Week679.9614.35
Two Weeks679.9614.35
One Month679.9576.85
Three Months679.9493.05
Six Months679.9432.2
One Year707.0427.0

Key Moving Average

5 Days 639.07637.919
15 Days 623.373627.479
20 Days 622.49622.778
50 Days 588.603594.38
100 Days 545.501566.049
200 Days 528.153551.916
Detailed MA Analysis of AARTIDRUGS ...

Key Technical Indicators

MACD 13.35
RSI 59.81
RSI (Smooth) 60.16
ADX 39.63
Chaikin Money Flow -0.162
Williams %R -35.23
PSAR 595.62
Detailed Tech Analysis AARTIDRUGS ...

Financial Data Highlights

Market Cap1426.40
Book Value/ Share244.56
Enterprise Value250.78
Revenue TTM1815.57
Gross Profit TTM494.71
Revenue /Share TTM774.71
Consensus Target0
Key Financial Highlights AARTIDRUGS ...

Financial Ratios of AARTIDRUGS

Div Yield0.480
Trailing PE13.21
Forward PE0
Key Financial Ratios of AARTIDRUGS ...

Key Profit & Loss Data

Net Inc 89.75 9.04 %
Ops Income166.05 4.60 %
Revenue1560.94 25.51 %
Ops Expense1394.89 28.58 %
PBT131.02 5.24 %
Gross Profit494.71 8.74 %
Div Paid-2.43 0 %

Price Range (PR) /Volatility

PeriodAvg PR Range %
LBD PR24.903.87
Week PR52.458.15
Month PR103.0516.01
5 Day Period40.016.39
10 Day Period28.554.57
5 Week Period62.4710.44
3 Months Period97.6517.22
Price Range /Volatility AARTIDRUGS ...

Highlights & Chart Patterns of Aarti Drugs

Stock has jumped by more than 25% in last three Month from its lowest level of 493.05 dt 17-Dec-19.
Share is making strong moves on recent weekly chart. Such movements may give an opportunity for short term trading.
Stock - Aarti Drugs has gud price range with fall in vol market in uptrend
Stock - Aarti Drugs has gud price range with fall in vol market in uptrend
Stock - Aarti Drugs has made higher level with higher volume market in uptrend
Spinning top Candlestick pattern was formed by Aarti Drugs on 18/02/2020 Prior to pattern formation this share was in uptrend.
As Per ADX, stock is in trend with ADX of 39.6325 and is trending for 38 Days
More Chart Patterns Aarti Drugs ...
You can now customize Equity with technical , SMA , Fin Data, chart patterns in one Page. Click here to view guide

Share Price History of Aarti Drugs

Date Open High Low Close Volume
19-Feb-20 637.70 660.00 635.10 643.60 30432
18-Feb-20 640.00 655.00 622.55 637.20 27257
17-Feb-20 660.05 675.00 631.00 635.10 49208
14-Feb-20 622.95 679.90 621.20 654.05 123 K
13-Feb-20 615.00 633.90 614.35 625.40 10201
12-Feb-20 621.05 627.65 615.00 618.60 13756
11-Feb-20 635.00 635.00 621.60 622.65 8853
10-Feb-20 625.00 642.00 624.65 631.05 15260
07-Feb-20 644.00 657.95 624.00 631.50 96955
06-Feb-20 635.00 638.00 617.00 628.30 22048
About Aarti Drugs Limited
Aarti Drugs Limited, through its subsidiaries, engages in the pharmaceuticals business in India and internationally. It offers active pharmaceutical ingredients in various therapeutic categories, including anti-inflammatory, cardioprotectants, antidiarrhoeals, antifungals, antiarthritis/osteoporosis, antibiotics, antidiabetics, Alzheimer's treatment, sedatives, vitamins, and alcoholism treatment. The company also provides pharmaceutical intermediate products comprising tinidazole, celecoxib, ciprofloxacin, clopidogrel, diclofenac, ketoconazole, nimesulide, raloxifene, and zolpidem; and specialty chemical products, such as benzene sulphonamide, benzene sulphonic acid, benzene sulphonic acid methyl ester, benzene sulphonyl chloride, cipro Q acid, levofloxacin Q acid, methyl nicotinate, N-methyl methane sulphonamide, diphenyl sulphone, norofloxacin Q acid, ofloxacin Q acid, ortho para toluene sulphonamide, ortho/para toluene sulphonic acid methyl ester, para chloro benzene sulphonamide, para chloro benzene sulphonyl chloride, para toluene sulphonamide, para toluene sulphonic acid methyl ester, para toluene sulphonyl chloride, and sodium benezene sulfinate. In addition, its products under development comprise Acamprosate for alcoholism; Dabigatran for use as an anticoagulant; Sevelamer for antihyperphosphatemia; Colsevelam for anti-cholestrol treatment; Drondarone and Olmesartan for the treatment of cardiovascular diseases; Valasartan for use as cardiprotectant; and Sitagliptin for use as an antidiabetic. Further, the company's pipeline product includes Mesalamine/Mesalazine and Loxoprofen Sodium for use as anti-inflammatory products; and Duloxetine for use as an antidepressant. Additionally, it offers contract manufacturing services. Aarti Drugs Limited was founded in 1984 and is based in Mumbai, India.
About Strength

Strength is based on Deep Analysis, Back Testing and Historical Trend Analysis using Machine Learning. Overall Technical Strength is based on 50+ indicators including Technicals, moving Avg, chart patterns, candlestick and proprietary algorithms.Technical Strength is currently calculated around around 5 to 6 PM. This is an automated process and in NO WAY should be considered as a tip as its based on past data. We strongly recommend to use these signals for information only and seek advise from a certified professional for any trading decision.If you like it then please share. The more the visitors the more the innovations. Feedback

We are working on fundamental strength also. Please share your views to help shape up the requirement.

( Intraday Analysis is on 15 Mins Delayed Data. All Other analysis is based on End of Trade day's Value. Expected time of update is between 5 to 5.30 PM exchange time Zone)

All Rights Reserved By Mintnovate Market Research Pvt Ltd.